BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Larson RE, Semelka RC. Magnetic resonance imaging of the liver. Top Magn Reson Imaging. 1995;7:71-81. [PMID: 7772372 DOI: 10.1097/00002142-199500720-00003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011;80:310-315. [PMID: 20732773 DOI: 10.1016/j.ejrad.2010.07.026] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
2 Theriault RL. Breast Cancer During Pregnancy. In: Singletary SE, editor. Breast Cancer. New York: Springer; 1999. pp. 253-61. [DOI: 10.1007/978-1-4612-2146-3_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
3 Semelka RC, Chung J, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: Correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-91. [DOI: 10.1002/jmri.1055] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
4 Lee JY, Kim SH, Jeon YH, Lee J, Kim MJ, Choi D, Lee WJ. Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experience. Journal of Computer Assisted Tomography 2010;34:127-34. [DOI: 10.1097/rct.0b013e3181b1587a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
5 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
6 Harisinghani MG, Jhaveri KS, Weissleder R, Schima W, Saini S, Hahn PF, Mueller PR. MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001;56:714-725. [PMID: 11585393 DOI: 10.1053/crad.2001.0764] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
7 Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217:152-158. [PMID: 11012438 DOI: 10.1148/radiology.217.1.r00oc31152] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 6.4] [Reference Citation Analysis]
8 Sharma P, Kalb B, Kitajima HD, Salman KN, Burrow B, Ray GL, Martin DR. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging. J Magn Reson Imaging. 2011;33:110-118. [PMID: 21182128 DOI: 10.1002/jmri.22200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
9 Robinson P. The characterization of liver tumours by MRI. Clinical Radiology 1996;51:749-61. [DOI: 10.1016/s0009-9260(96)80002-x] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
10 Herborn CU, Vogt F, Lauenstein TC, Goyen M, Debatin JF, Ruehm SG. MRI of the liver: Can true FISP replace HASTE? J Magn Reson Imaging 2003;17:190-6. [DOI: 10.1002/jmri.10248] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]